Sodium Deoxyribonucleotide

HIV Drugs Show Promising Potential to Reduce Alzheimer's Risk by Up to 13% Annually

14 days ago

• UVA Health researchers discovered that HIV medications called NRTIs significantly reduce Alzheimer's risk, with annual decreases of 6-13% observed across two major health insurance databases. • The protective effect appears specific to NRTIs, which block inflammasomes linked to Alzheimer's development, and could potentially prevent approximately 1 million new cases worldwide each year. • Researchers are now calling for clinical trials of both existing NRTIs and a newly developed inflammasome-blocking drug called K9, which they describe as a safer and more effective alternative.

Sodium Deoxyribonucleotide

HIV Drugs Show Promising Potential to Reduce Alzheimer's Risk by Up to 13% Annually

Drug Development Updates